Federal RuleAug 21
62
DOL Rewrites Disability Rules for 'Merit-Based Opportunity' Push
RuleLabor DepartmentFederal Contract Compliance Programs OfficeSignificant Wallet
119-hr-10227119th CongressWALLET
INSULIN Act of 2026
Sponsored By: Representative DeGette, Diana [D-CO-1]
Introduced
Summary
Reduce out-of-pocket costs for insulin while expanding patient supports and creating a faster pathway for biosimilar competition to try to bring down prices and improve access.
Personalized for You
How does this bill affect your finances?
Personalize government policy and PRIA will tell you what this bill means for your household, plus every other piece of legislation we track. PRIA reads each provision against your financial profile to show you exactly what matters to your wallet.
Bill Overview
Analyzed Economic Effects
5 provisions identified: 5 benefits, 0 costs, 0 mixed.
Lower insulin costs for insured people
If enacted, group and individual health plans would have to cover selected insulin products with no deductible. For each 30-day supply you would pay the lesser of $35 or 25% of the negotiated price after price concessions. Before 2028 a $35 per-30-day cap would apply. Plans generally could not require prior authorization for selected insulin, and plans could limit coverage to the plan's chosen "selected insulin products" (at least one dosage form and device per insulin type).
Faster review pathway for biosimilars
If enacted, the Secretary would be able to designate a biosimilar as a "competitive biosimilar" and allow expedited development and review. Sponsors could request the designation with or up to 60 days before their application, and the Secretary could decide within 60 days. The designation would apply only when there are fewer than three licensed products using the reference biologic and at least three years have passed since expiration of all applicable exclusivity.
Help for uninsured people needing insulin
If enacted, HHS would award grants to set up an insulin resource center and a 24/7 voice-and-text hotline to help uninsured people find affordable insulin. Grantees would run a ZIP-code searchable website linking to health centers and pharmacies, give impartial info about assistance programs, help people enroll, provide culturally and linguistically appropriate help, and do outreach with hospitals and community groups. Grantees could not be insulin manufacturers or accept manufacturer payments tied to enrollment. The program is authorized $2,000,000 per year for fiscal years 2027 through 2032.
Patient protections and timing rules
If enacted, selected insulin benefits would get existing patient-protection rules for plan years starting January 1, 2028. The bill would also say removing a deductible for those insulin products would not count as raising a plan's actuarial value for marketplace rules. HHS, Labor, and Treasury would be allowed to implement these title rules by guidance for plan years starting Jan 1, 2028 and ending no later than Jan 1, 2030, and the Paperwork Reduction Act would not apply to these provisions.
Study on uninsured insulin users
If enacted, the Government Accountability Office would study uninsured people who use insulin and report within two years of enactment. The report would look at where they live, why they are uninsured, race and ethnicity, and income levels, and it would consult patient, clinical, and provider groups and other experts.
Sponsors & CoSponsors
Sponsor
DeGette, Diana [D-CO-1]
CO • D
Cosponsors
Rep. Escobar, Veronica [D-TX-16]
TX • D
Sponsored 10/5/2026
Rep. Gottheimer, Josh [D-NJ-5]
NJ • D
Sponsored 11/2/2026
Rep. Jayapal, Pramila [D-WA-7]
WA • D
Sponsored 9/24/2026
Rep. Vasquez, Gabe [D-NM-2]
NM • D
Sponsored 9/24/2026
Rep. Pappas, Chris [D-NH-1]
NH • D
Sponsored 9/24/2026
Rep. Tlaib, Rashida [D-MI-12]
MI • D
Sponsored 9/24/2026
Rep. DelBene, Suzan K. [D-WA-1]
WA • D
Sponsored 9/24/2026
Rep. Miller-Meeks, Mariannette [R-IA-1]
IA • R
Sponsored 9/2/2026
Rep. Schrier, Kim [D-WA-8]
WA • D
Sponsored 9/2/2026
Rep. Bresnahan, Robert P. [R-PA-8]
PA • R
Sponsored 9/2/2026
Rep. Craig, Angie [D-MN-2]
MN • D
Sponsored 9/2/2026
Rep. Mackenzie, Ryan [R-PA-7]
PA • R
Sponsored 9/8/2026
Rep. Mannion, John W. [D-NY-22]
NY • D
Sponsored 9/8/2026
Rep. Castro, Joaquin [D-TX-20]
TX • D
Sponsored 9/8/2026
Rep. Budzinski, Nikki [D-IL-13]
IL • D
Sponsored 9/14/2026
Rep. Cleaver, Emanuel [D-MO-5]
MO • D
Sponsored 9/14/2026
Rep. Riley, Josh [D-NY-19]
NY • D
Sponsored 9/14/2026
Rep. Davids, Sharice [D-KS-3]
KS • D
Sponsored 9/14/2026
Rep. Hayes, Jahana [D-CT-5]
CT • D
Sponsored 9/21/2026
Rep. Ivey, Glenn [D-MD-4]
MD • D
Sponsored 9/21/2026
Roll Call Votes
No roll call votes available for this bill.
View on Congress.gov